Vaccine Shortage: What Moderna, Johnson & Johnson, Novavax and Co. are now planning

Vaccine shortages have been the dominant issue in recent weeks.

But meanwhile there are signs of a change for the better.

Several manufacturers want to expand their production volumes, and now there are even two more promising candidates in the starting blocks.

This could also help Germany to increase the pace of immunization of the population after the start of the vaccination has failed.